HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corrigendum to: Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130).

AuthorsHiroji Iwata, Kenichi Inoue, Koji Kaneko, Yoshinori Ito, Koichiro Tsugawa, Ayumi Hasegawa, Shintaro Nakagawa, Hiroyasu Kuratomi, Kenji Tamura
JournalJapanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 50 Issue 2 Pg. 223 (02 17 2020) ISSN: 1465-3621 [Electronic] England
PMID31950142 (Publication Type: Journal Article, Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: